A carregar...

CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment

Despite the development of targeted therapies and novel inhibitors, cancer remains an undefeated disease. Resistance mechanisms arise quickly and alternative treatment options are urgently required, which may be partially met by drug combinations. Protein kinases as signaling switchboards are freque...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceuticals (Basel)
Main Authors: Scheiblecker, Lisa, Kollmann, Karoline, Sexl, Veronika
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760252/
https://ncbi.nlm.nih.gov/pubmed/33255177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120418
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!